{"contentid": 487958, "importid": NaN, "name": "Stada Arz names global head of specialties", "introduction": "Experienced life sciences leader Bryan Chu Young Kim will strengthen the global leadership team at German drugmaker Stada Arzneimittel as head of global specialties, effective April 1, 2021.", "content": "<p>Experienced life sciences leader Bryan Chu Young Kim will strengthen the global leadership team at German drugmaker Stada Arzneimittel (SAZ: Xetra) as head of global specialties, effective April 1, 2021.</p>\n<p>Mr Kim will oversee Stada&rsquo;s rapidly expanding portfolio and pipeline of differentiated prescription Specialty Pharmaceuticals, reporting to Stada chief executive Peter Goldschmidt.</p>\n<p>&ldquo;I am delighted to bring Bryan into our global leadership team,&rdquo; said Mr Goldschmidt, adding: &ldquo;His extensive experience and expertise fits perfectly with Stada&rsquo;s growing portfolio and pipeline of Specialty Pharmaceuticals, which complements our leading positions in Consumer Healthcare and Generics.&rdquo;</p>\n<p>Mr Kim brings more than 20 years of healthcare and pharmaceutical experience, gathered across the US, Europe and Asia. In particular, he has detailed knowledge of central nervous system therapies, an area in which Stada is building a comprehensive, differentiated Parkinson&rsquo;s disease portfolio with a unique triple-combination pump product complementing the group&rsquo;s established apomorphine-based therapies.&nbsp;</p>\n<p>In recent years, Mr Kim has focused particularly on biologic drugs, including follow-on biosimilar medicines. Mr Kim was most recently vice president, corporate development, at South Korean biosimilars developer and manufacturer Samsung Bioepis. In this role, he led a team of business-development professionals and oversaw all biosimilar licensing, alliance and other deals.</p>\n<p>During more than four years with Boehringer Ingelheim, Mr Kim worked on biosimilars, as well as on global launches and marketing of respiratory brands. He also led the German company&rsquo;s prescription medicines business as regional executive director for Greater China, South Korea, South-East Asia and India.</p>", "date": "2021-03-05 12:18:00", "meta_title": "Stada Arz names global head of specialties", "meta_keywords": "Stada Arzneimittel, Appointment, Bryan Chu Young Kim, Head, Global specialties", "meta_description": "Stada Arz names global head of specialties", "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 3, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-03-05 12:17:56", "updated": "2021-03-05 12:24:14", "access": NaN, "url": "https://www.thepharmaletter.com/article/stada-arz-names-global-head-of-specialties", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "stada-location-big.jpg", "image2id": "stada-location-small.jpg", "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": NaN, "sector_tag": "Generics", "therapy area_tag": NaN, "topic_tag": "Boardroom, Management", "geography_tag": "Germany", "company_tag": "STADA Arzneimittel", "drug_tag": NaN, "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": "Bryan Chu Young Kim", "position_tag": NaN, "medical treatment_tag": NaN, "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-03-05 12:18:00"}